NCT01430091 A Relative Bioavailability Study of a Prasugrel Orally Disintegrating Tablet Status COMPLETED Phase PHASE1
NCT01419977 Treatment of Sickle Cell Patients Hospitalized in Pain Crisis With Prophylactic Dose Low-molecular-weight Heparin (LMWH) Versus Placebo Status COMPLETED Phase PHASE2
NCT01411280 Ameliorating Attention Problems in Children With Sickle Cell Disease (SCD) Status COMPLETED Phase PHASE3
NCT01380197 Choosing Opioid Management for Pain and Analyzing Acute Chest Syndrome (ACS) Rates Equally Status COMPLETED Phase PHASE3
NCT01374165 Safety and Pharmacokinetics of SANGUINATE™ in Sickle Cell Disease (SCD) Patients Status WITHDRAWN Phase N/A
NCT01369160 Curative Versus Disease-Modifying Therapies in Children With Severe Sickle Cell Disease Status COMPLETED Phase N/A
NCT01319851 Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation Status TERMINATED Phase NA
NCT01316796 Topical Sodium Nitrite for Chronic Leg Ulcers in Adult Patients With Blood Disorders Status COMPLETED Phase PHASE1
NCT01316549 Study of Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation Status COMPLETED Phase N/A
NCT01294891 Microvascular and Cardiac Dysfunction in Paroxysmal Nocturnal Hemoglobinuria and Sickle Cell Disease Status COMPLETED Phase N/A
NCT01279616 A Reduced Toxicity Allogeneic Unrelated Donor Stem Cell Transplantation (SCT) for Severe Sickle Cell Disease Status TERMINATED Phase PHASE2
NCT01276587 Study of Vitamin D in Children With Sickle Cell Disease Status COMPLETED Phase PHASE1/PHASE2
NCT01256281 Regional Anesthesia for Sickle Cell Crisis Using Ultrasound in The Emergency Department: Phase I Status TERMINATED Phase PHASE1
NCT01245179 Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease Status RECRUITING Phase PHASE1